News
CNW/ – Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, as of July 2, 2025, Pluvicto® (lutetium (177Lu) vipivotide tetraxetan injection) is ...
Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the “Company” or “Cymat”) is pleased to announce that Michael Liik, Cymat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback